CD79A and glomerular disorder: The CureGN study, a large multicenter prospective observational cohort study commissioned by the National Institute of Diabetes and Digestive and Kidney Disease, aimed to deepen epidemiologic, clinical, and biochemical correlations of several glomerulopathies, including IgA‐related disease.94